Staphylococcal peroxidase inhibitor (SPIN): Residue-level investigation of the helical bundle domain
Archives of Biochemistry and Biophysics · 2024
DOI: 10.1016/j.abb.2024.110023 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Biochemistry and Biophysics, 2024. Verfasst von Soheila Fatehi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry & Molecular Biophysics, Kansas State University, Manhattan, KS, 66506, USA. Hauptthemen laut MEDLINE: Staphylococcus aureus, Peroxidase. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, National Institute of General Medical Sciences, National Institutes of Health.
Abstract (Originalsprache)
Myeloperoxidase is a critical component of the antibacterial arsenal of neutrophils, whereby it consumes H2O2 as an oxidant to convert halogen and pseudohalogen anions into cytotoxic hypohalous acids. Following phagocytosis by neutrophils, the human pathogen Staphylococcus aureus secretes a potent myeloperoxidase inhibitory protein, called SPIN, as part of its immune evasion repertoire. The matured S. aureus SPIN polypeptide consists of only 73 residues yet contains two functional domains: whereas the 60 residue C-terminal helical bundle domain is responsible for MPO binding, the 13 residue N-terminal domain is required to inhibit MPO. Previous studies have informed understanding of the SPIN N-terminal domain, but comparatively little is known about the helical domain insofar as the contribution of individual residues is concerned. To address this limitation, we carried out a residue-level structure/function investigation on the helical bundle domain of S. aureus SPIN. Using sequence conservation and existing structures of SPIN bound to human MPO as a guide, we selected residues L49, E50, H51, E52, Y55, and Y75 for interrogation by site-directed mutagenesis. We found that loss of L49 or E52 reduced SPIN activity by roughly an order of magnitude, but that loss of Y55 or H51 caused progressively greater loss of inhibitory potency. Direct binding studies by SPR showed that loss of inhibitory potency in these SPIN mutants resulted from a diminished initial interaction between the inhibitor and MPO. Together, our studies provide new insights into the structure/function relationships of SPIN and identify positions Y55 and H51 as critical determinants of SPIN function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry & Molecular Biophysics, Kansas State University, Manhattan, KS, 66506, USA.
- Department of Biochemistry & Molecular Biophysics, Kansas State University, Manhattan, KS, 66506, USA. Electronic address: geisbrechtb@ksu.edu.
Förderung
- NIGMS NIH HHS
- National Institute of General Medical Sciences
- National Institutes of Health
Zitieren
APA
Fatehi, S., Herdendorf, T. J., Ploscariu, N. T., & Geisbrecht, B. V. (2024). Staphylococcal peroxidase inhibitor (SPIN): Residue-level investigation of the helical bundle domain. Archives of Biochemistry and Biophysics. https://doi.org/10.1016/j.abb.2024.110023
Vancouver
Fatehi S, Herdendorf TJ, Ploscariu NT, Geisbrecht BV. Staphylococcal peroxidase inhibitor (SPIN): Residue-level investigation of the helical bundle domain. Archives of Biochemistry and Biophysics. 2024. doi:10.1016/j.abb.2024.110023
BibTeX
@article{Fatehi2024,
author = {Fatehi, Soheila and Herdendorf, Timothy J and Ploscariu, Nicoleta T and Geisbrecht, Brian V},
title = {Staphylococcal peroxidase inhibitor (SPIN): Residue-level investigation of the helical bundle domain},
journal = {Archives of Biochemistry and Biophysics},
year = {2024},
doi = {10.1016/j.abb.2024.110023}
}
EUVIMED